Pfizer
ORG
Pfizer
Pfizer, the New York-based drugmaker is set for its annual meeting. Even though the stock has lost 43 percent of its value since Dr. McKinnell became Pfizer's chief in January 2001. Pfizer shareholders could pay even more than $83 million. The Pfizer situation makes an interesting test, not only of Pfizer's commitment to listening to shareholders but also of whether money managers will side with Pfizer or their investor customers who have lost money in the company's shares.